Drawing for LIFE YEARS AHEAD

USPTO serial 87477148

LIFE YEARS AHEAD

Reviewed by CopyMark Law Group

Reg. 5686824Status 711
Filing date
Status date
Registration date
Feb 26, 2019
Examiner
NITKIN, DINISHA F
Law office
TMO LAW OFFICE 110

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LIFE YEARS AHEAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Medical testing and research services, namely, conducting clinical trials and surveillance studies in the nature of post-market monitoring of the safety of pharmaceuticals and medical devices for the health care industrySECTION 7(e) - CANCELLEDOct 1, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2020C7..CANCELLED SECTION 7-TOTAL
Nov 17, 2020NCS7NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Nov 16, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 16, 2020C7RFREQUEST FOR SECT 7 TOTAL SURRENDER FILED
Jul 16, 2020ES7STEAS SECTION 7 SURRENDER RECEIVED
Feb 26, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 25, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 24, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 12, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jan 12, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 10, 2018IUAFUSE AMENDMENT FILED
Dec 10, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 12, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 8, 2018EX1GSOU EXTENSION 1 GRANTED
Jun 8, 2018EXT1SOU EXTENSION 1 FILED
Jun 8, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 26, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 31, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 26, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 25, 2017ALIEASSIGNED TO LIE
Sep 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2017XAECEXAMINER'S AMENDMENT ENTERED
Sep 8, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 8, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Sep 8, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 6, 2017DOCKASSIGNED TO EXAMINER
Jun 13, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance